On December 22, 2025, the FDA approved oral Wegovy (semaglutide 25mg tablet) the first and only oral GLP-1 medication for chronic weight management
Note: Cannabis is illegal at a federal level but is legal in many states to varying degrees
K., Thomsen, M., Wortwein, G., & Fink-Jensen, A
The practical sweet spot Most experienced researchers find that prefilling 2-3 weeks of doses strikes the right balance between convenience and safety
The timing of your semaglutide injection can affect appetite at different times of day
GLP-1s do not relieve stress or treat the underlying stressors. It is possible that GLP-1s can help suppress emotional eating: Esposito says that the feeling of fullness they provide could make overeating in response to emotional stress less desirable